key: cord-0902514-eyqq9j21
authors: Amatya, Bhawana; Pandey, Prativa; Dawadi, Suvash; Manandhar, Shanta
title: COVID-19 in fully vaccinated Everest trekkers in Nepal
date: 2021-07-06
journal: J Travel Med
DOI: 10.1093/jtm/taab098
sha: 25975a4639100947e82b7b9ed01d4e506acda9f5
doc_id: 902514
cord_uid: eyqq9j21

COVID-19 in a fully mRNA-1273 vaccinated aspiring Everest summiteer and an Everest trekker who had two doses of ChAdOx1nCoV-19 are presented. Delta B.1.617.2 variant was sequenced in one of the cases. Travellers should be wary of starting up travel to under-vaccinated regions, particularly if they are at high risk for severe disease.

Trekking exposes travellers to tight indoor quarters where social distancing cannot be maintained, and respiratory infections can spread rapidly. 6 Cold temperatures drive people 

Health problems in travellers to Nepal visiting CIWEC clinic in Kathmandu -A GeoSentinel analysis

Vaccine Breakthrough Infections with SARS-CoV-2 Variants

Effectiveness of COVID-19 vaccines against the B.1.617.2 variant

1.617.2 and B.1.351 by BNT162b2 vaccination

BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses

An outbreak of influenza among trekkers in the Everest region of Nepal

Acknowledgements: The authors would like to thank the doctors, nurses and staff at CIWEC for helping to take care of the patients mentioned in the case reports.